Bafna PharmaceuticalsBAFNAPH 
$0.972.95%24h
2.95%24h
Global rank29394
Market cap$22.94M
Change 7d0.66%
YTD Performance-11.60%
SP500 benchmarkUnderperform
P/E0.20
P/S1.67
Revenue$13.75M
Earnings$1.35M
Dividend yield-
Main Sector
Healthcare
Category
Bafna Pharmaceuticals BAFNAPH Total Debt
BAFNAPH Total Debt in 2022: $1.01M
According to Bafna Pharmaceuticals latest financial reports the total debt is $1.01M, an increase of 58.61% to 2022. At the end of 2022 company had $633.84K total debt. This figure represents the debts and financial obligations that Bafna Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Bafna Pharmaceuticals BAFNAPH Total Debt History from 2023 to 2022
-
Value:-
BAFNAPH Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $1.01M | 58.61% |
| 2022 | $633.84K | 112.68% |
| 2021 | $298.03K | -17.15% |
| 2020 | $359.73K | -86.87% |
| 2019 | $2.74M | - |
View the Top Total Debt Stocks 
